Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
3.09B | 2.82B | 2.72B | 2.71B | 2.22B | Gross Profit |
3.09B | 2.48B | 2.40B | 2.41B | 1.97B | EBIT |
1.03B | 1.79B | 526.02M | 437.97M | 445.66M | EBITDA |
1.03B | 2.60B | 681.39M | 703.98M | 553.27M | Net Income Common Stockholders |
470.52M | 576.60M | 373.01M | 373.36M | 386.16M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
1.68B | 1.62B | 3.05B | 3.18B | 3.01B | Total Assets |
14.58B | 15.03B | 15.35B | 16.12B | 14.91B | Total Debt |
1.95B | 2.04B | 2.08B | 2.04B | 1.77B | Net Debt |
1.27B | 1.43B | 1.59B | 1.65B | 1.23B | Total Liabilities |
12.32B | 12.96B | 13.63B | 14.03B | 13.07B | Stockholders Equity |
2.26B | 2.07B | 1.72B | 2.08B | 1.84B |
Cash Flow | Free Cash Flow | |||
832.86M | 658.62M | 731.86M | 632.27M | 615.79M | Operating Cash Flow |
862.09M | 692.52M | 757.66M | 656.96M | 643.42M | Investing Cash Flow |
-232.25M | -90.05M | -200.05M | -923.38M | -53.53M | Financing Cash Flow |
-551.14M | -479.62M | -457.85M | 107.97M | -301.79M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | $14.30B | 9.67 | 14.68% | 2.05% | 1.69% | 25.54% | |
75 Outperform | $9.15B | 18.80 | 23.87% | 1.29% | 10.18% | -9.75% | |
74 Outperform | $10.09B | 9.94 | 20.47% | 0.81% | 5.41% | 16.60% | |
70 Outperform | $4.36B | 8.75 | 12.72% | 2.66% | -1.72% | 95.91% | |
69 Neutral | $6.08B | 82.88 | 1.24% | 3.41% | 3.55% | 8.91% | |
64 Neutral | $5.85B | 4.87 | 16.91% | 5.30% | 8.31% | -2.30% | |
64 Neutral | $12.78B | 9.87 | 7.67% | 17015.06% | 12.34% | -5.99% |
Primerica held its 2025 annual stockholders’ meeting on May 14, 2025, where 90% of the outstanding shares were represented. During the meeting, several key proposals were addressed: the election of board members, approval of executive compensation, and the ratification of KPMG LLP as the independent public accounting firm for the fiscal year ending December 31, 2025.
The most recent analyst rating on (PRI) stock is a Buy with a $340.00 price target. To see the full list of analyst forecasts on Primerica stock, see the PRI Stock Forecast page.
On May 7, 2025, Primerica, Inc. announced its financial results for the first quarter ending March 31, 2025. The company reported a 9% increase in total revenues to $804.8 million, with net income rising 14% to $169.1 million compared to the previous year. The life-licensed sales force grew by 7% year-over-year, and investment and savings product sales reached a record $3.6 billion, up 28%. The results reflect the strength of Primerica’s business model and its ability to attract new recruits, despite economic uncertainties impacting productivity.